Correlations between serum leptin levels and classical biomarkers in SARS-CoV-2 infection, in critically ill patients.

[1]  A. Larsson,et al.  Plasma Leptin Is Increased in Intensive Care Patients with COVID-19—An Investigation Performed in the PronMed-Cohort , 2021, Biomedicines.

[2]  Evan T. Sholle,et al.  Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 , 2021, Cell Metabolism.

[3]  Prince Sebastian,et al.  COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality , 2021, Frontiers in Immunology.

[4]  B. Bonnotte,et al.  Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19? , 2021, International Journal of Obesity.

[5]  J. Bonventre,et al.  Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection , 2021, Nature Metabolism.

[6]  Karin de Punder,et al.  Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review , 2021, Cells.

[7]  Jianquan Li,et al.  Unexplained elevation of erythrocyte sedimentation rate in a patient recovering from COVID-19: A case report , 2021, World journal of clinical cases.

[8]  W. Jia,et al.  Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring , 2021, Diabetes Care.

[9]  Beizhong Liu,et al.  Leptin correlates with monocytes activation and severe condition in COVID-19 patients , 2021, Journal of leukocyte biology.

[10]  Z. Gazzaz.  Diabetes and COVID-19 , 2021, Open life sciences.

[11]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[12]  C. Lodigiani,et al.  Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study , 2020, Journal of clinical medicine.

[13]  J. Bae,et al.  COVID-19 and diabetes mellitus: from pathophysiology to clinical management , 2020, Nature Reviews Endocrinology.

[14]  R. Danieli,et al.  COVID-19: Is there a role for immunonutrition in obese patient? , 2020, Journal of translational medicine.

[15]  Abdel-Naser Elzouki,et al.  D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review , 2020, Vascular health and risk management.

[16]  Majid Ali,et al.  Neutrophil/lymphocyte ratio—A marker of COVID‐19 pneumonia severity , 2020, International journal of clinical practice.

[17]  S. Solomon,et al.  Severe COVID-19 Is a Microvascular Disease , 2020, Circulation.

[18]  M. van Meurs,et al.  Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue , 2020, Heliyon.

[19]  Ž. Vlaisavljević,et al.  Diabetes and COVID-19: A systematic review on the current evidences , 2020, Diabetes Research and Clinical Practice.

[20]  F. Greenway,et al.  Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? , 2020, International Journal of Obesity.

[21]  G. Cohen.  Immune Dysfunction in Uremia 2020 , 2020, Toxins.

[22]  Nurshad Ali.  Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19 , 2020, Journal of medical virology.

[23]  Mario Plebani,et al.  Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis , 2020, The American Journal of Emergency Medicine.

[24]  B. Sarmento,et al.  SARS-CoV-2 and diabetes: New challenges for the disease , 2020, Diabetes Research and Clinical Practice.

[25]  T. Stulnig,et al.  Diabetes and COVID-19 , 2020, Wiener klinische Wochenschrift.

[26]  Akhtar Hussain,et al.  COVID-19 and diabetes: Knowledge in progress , 2020, Diabetes Research and Clinical Practice.

[27]  Y. Xiong,et al.  Clinical features and treatment of COVID‐19 patients in northeast Chongqing , 2020, Journal of medical virology.

[28]  Jie Zhang,et al.  Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis , 2020, Respiratory Research.

[29]  Rui-guang Zhang,et al.  Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Wenjuan Wu,et al.  Highly ACE2 Expression in Pancreas May Cause Pancreas Damage After SARS-CoV-2 Infection , 2020, medRxiv.

[31]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[32]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[33]  Jing Yuan,et al.  Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.

[34]  G. De Sarro,et al.  IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes , 2019, Medicine.

[35]  P. Bhattacharya,et al.  Leptin Functions in Infectious Diseases , 2018, Front. Immunol..

[36]  M. Donath,et al.  IL-6–Type Cytokine Signaling in Adipocytes Induces Intestinal GLP-1 Secretion , 2017, Diabetes.

[37]  G. Hallmans,et al.  Leptin independently predicts development of sepsis and its outcome , 2017, Journal of Inflammation.

[38]  T. Kieffer,et al.  The glucoregulatory actions of leptin , 2017, Molecular metabolism.

[39]  S. Perlman,et al.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.

[40]  S. Perlman,et al.  Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus. , 2017, Annual review of medicine.

[41]  G. Stoddard,et al.  Adipocyte iron regulates leptin and food intake. , 2015, The Journal of clinical investigation.

[42]  M. Fasshauer,et al.  Adipokines in health and disease. , 2015, Trends in pharmacological sciences.

[43]  K. Limesand,et al.  Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms , 2014, Aging cell.

[44]  S. Konstantinides,et al.  Mechanisms linking leptin to arterial and venous thrombosis: potential pharmacological targets. , 2014, Current pharmaceutical design.

[45]  Kenneth W. Scully,et al.  Role of Leptin-Mediated Colonic Inflammation in Defense against Clostridium difficile Colitis , 2013, Infection and Immunity.

[46]  Y. Shoenfeld,et al.  The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome , 2013, BMC Medicine.

[47]  J. Tavernier,et al.  Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. , 2013, Pulmonary pharmacology & therapeutics.

[48]  K. To,et al.  Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. , 2013, The Journal of infectious diseases.

[49]  M. Wong,et al.  Leptin therapy, insulin sensitivity, and glucose homeostasis , 2012, Indian journal of endocrinology and metabolism.

[50]  M. Borggrefe,et al.  Alterations of leptin in the course of inflammation and severe sepsis , 2012, BMC Infectious Diseases.

[51]  Stephen S. H. Huang,et al.  Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection , 2012, PloS one.

[52]  T. Kieffer,et al.  The role of leptin in glucose homeostasis , 2012, Journal of diabetes investigation.

[53]  E. Wherry,et al.  Protein Energy Malnutrition Impairs Homeostatic Proliferation of Memory CD8 T Cells , 2012, The Journal of Immunology.

[54]  S. Konstantinides,et al.  Adipokines and thrombosis , 2011, Clinical and experimental pharmacology & physiology.

[55]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[56]  M. Reyes-Romero,et al.  Leptin in sepsis: a well-suited biomarker in critically ill patients? , 2010, Critical care.

[57]  Jin-Kui Yang,et al.  Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.

[58]  A. Shah,et al.  Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. , 2006, European heart journal.

[59]  L. Szczech,et al.  Leptin and Renal Disease , 2006, Seminars in dialysis.

[60]  M. Peters-Golden,et al.  Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[61]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[62]  B. Eliasson,et al.  Leptin levels in smokers and long‐term users of nicotine gum , 1999, European journal of clinical investigation.

[63]  S. Chandrasekaran,et al.  Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs. , 2016, Experimental parasitology.

[64]  M. Haluzík,et al.  Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNF-alpha but not with BMI. , 2001, Physiological research.

[65]  R. Curi,et al.  Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation , 1999, International Journal of Obesity.